Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Filings indexed 968 across all filing types
Latest filing 2021-12-19 Remuneration Information
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
Long-Term Incentive Plan - grant of share options to primary insiders
Remuneration Information Classification · 99% confidence The document explicitly details the grant of share options (a form of remuneration/incentive) to senior management (primary insiders) under an approved Long-Term Incentive Plan. This directly relates to executive compensation and insider transactions. While it involves insiders (suggesting DIRS), the primary focus is the granting of options as part of a compensation scheme approved by the AGM. This aligns most closely with the definition of Remuneration Information (DEF 14A), which covers compensation for top executives and directors. It is not a general Director's Dealing report (DIRS), which usually focuses on the *transaction* of existing shares, but rather the *grant* of new incentive instruments. Comparing options: - DIRS (Director's Dealing): Focuses on personal share transactions (buying/selling). This is an option grant. - DEF 14A (Remuneration Information): Covers compensation for top executives. Option grants are a key component of executive compensation. - SHA (Share Issue/Capital Change): This is an option grant, not a general share issue/split. Given the context of granting options to senior management under an incentive plan, DEF 14A is the most precise fit, as it covers executive remuneration details.
2021-12-19 English
Long-Term Incentive Plan - grant of share options to primary insiders
Remuneration Information Classification · 95% confidence The document explicitly details the grant of share options (a form of remuneration/incentive) to primary insiders (senior management) under a Long-Term Incentive Plan. This action directly relates to the compensation and incentives provided to directors and executives. While it involves shares, the core subject is the granting of options as part of executive compensation, which aligns most closely with Remuneration Information (DEF 14A). It is not a general Director's Dealing report (DIRS), as it is a planned grant, not a transaction of existing holdings, nor is it a general Share Issue (SHA) as it is targeted at insiders under a specific plan. Therefore, DEF 14A is the most appropriate classification.
2021-12-19 English
ArcticZymes Technologies ASA: Primary insider selling shares in connection with option program
Director's Dealing Classification · 99% confidence The document is explicitly titled 'Notification and public disclosure of transactions by primary insider' and details transactions (specifically 'Exercise of options') conducted by an individual identified as 'CEO / primary insider' (Jethro Holter) in the company's shares. This structure and content directly correspond to the definition of Director's Dealing, which covers personal share transactions by company directors and executives.
2021-12-10 English
ArcticZymes Technologies ASA: Primary insider selling shares in connection with option program
Director's Dealing Classification · 99% confidence The document explicitly details a transaction where the CEO, Jethro Holter, sold shares to cover tax obligations and the strike price following an option exercise. This is a report of personal share transactions by a company director/executive (insider trade). This directly matches the definition for Director's Dealing (DIRS). The text also mentions disclosure requirements under EU Market Abuse Regulation (MAR), confirming its nature as an insider transaction report.
2021-12-10 English
ArcticZymes Technologies ASA: Primary insider selling shares in connection with option program
Director's Dealing Classification · 99% confidence The document explicitly details a transaction where the CEO, Jethro Holter, sold shares immediately following an option exercise to cover tax obligations and the strike price. This is a report of personal share transactions by a company director/executive (insider trade). This directly matches the definition for Director's Dealing (DIRS). The text also references compliance with EU Market Abuse Regulation (MAR), which governs insider trading disclosures.
2021-12-10 English
ArcticZymes Technologies ASA: Primary insider exercising options
Director's Dealing Classification · 100% confidence The document is titled "Notification and public disclosure of transactions by primary insider" and details a transaction made by the CEO (Jethro Holter). Specifically, it reports the 'Exercise of options' involving a specific number of shares (200,000) on a specific date (2021-12-10). This type of filing, reporting personal share transactions by company directors and executives (insider trades), directly matches the definition for Director's Dealing.
2021-12-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.